Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Plos Pathogens|December 10, 2019
Disrupting MLV integrase:BET protein interaction biases integration into quiescent chromatin and delays but does not eliminate tumor activation in a MYC/Runx2 mouse modelLorenz Loyola, Vasudevan Achuthan, Kathryn Gilroy, et al.
Cancers|December 11, 2022
PKCβ Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated SignallingJodie Hay, Anuradha Tarafdar, Ailsa K Holroyd, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2018
AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated SurvivalEmilio Cosimo, Anuradha Tarafdar, Michael W Moles, et al.
Nature Medicine|October 15, 2021
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UKKoen B Pouwels, Emma Pritchard, Philippa C Matthews, et al.
Elife|July 12, 2021
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over timeA Sarah Walker, Emma Pritchard, Thomas House, et al.
Nature Communications|July 10, 2024
Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cellsHannah Donnelly, Ewan Ross, Yinbo Xiao, et al.
The EMBO Journal|May 30, 2024
IL-27 maintains cytotoxic Ly6C+ γδ T cells that arise from immature precursorsRobert Wiesheu, Sarah C Edwards, Ann Hedley, et al.
Lancet (London, England)|April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trialKatherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Pageof 2